-
WilmerHale Advises Xilio Therapeutics In $95M Series C Financing
2.25.2021On February 24, 2021, Xilio Therapeutics, a biotechnology company developing potent, tumor-selective immunotherapies for patients with cancer, announced the successful closing of a $95 million Series C financing round.
-
WilmerHale Advises Orna Therapeutics in $80M Series A Financing
2.24.2021On February 24, 2021, Orna Therapeutics, a biotechnology company dedicated to designing and delivering a new class of fully engineered circular RNA therapeutics (oRNAs), announced the completion of its $80 million Series A financing.
-
WilmerHale Represents WizeHire in $7.5M Series A Financing
2.19.2021On February 9, 2021, WizeHire, a user-friendly, effective hiring solution for small businesses, announced the closing of $7.5 million in Series A funding.
-
WilmerHale Advises Esme Learning Solutions in $7.5M Series A Financing
1.27.2021Esme Learning Solutions, a leading digital learning platform, announced the close of a $7.5 million Series A financing round led by Adit Ventures, a venture capital firm with a technology thematic investment focus.
-
WilmerHale Represents Verve Therapeutics in $94M Series B Financing
1.22.2021On January 19, 2021, Verve Therapeutics, a biotech company pioneering gene editing medicines to treat cardiovascular disease, announced the successful completion of a $94 million Series B financing.
-
WilmerHale Advises Werewolf Therapeutics in $72M Series B Financing
1.8.2021On January 7, 2021, Werewolf Therapeutics, an oncology biotherapeutics company advancing a pipeline of next-generation, transformative cancer treatments, announced the completion of its $72 million Series B financing.
-
WilmerHale Represents The Lifetime Value Co. in $150M Investment
12.17.2020On December 17, 2020, The Lifetime Value Co., a creator of leading online consumer and business information brands that helps people discover, understand and use data, announced a $150 million investment led by Morgan Stanley Expansion Capital with participation from investment funds managed by Morgan Stanley Credit Partners, Morgan Stanley Tactical Value, and ROCA Partners.
-
WilmerHale Represents MineralTree in $50M Series D Funding Round and Acquisition of Regal Software
9.25.2020On September 24, 2020, MineralTree, an Accounts Payable (AP) and payments automation solution provider, announced that it has closed a $50 million Series D investment round with participation from existing investors Great Hill Partners, .406 Ventures and Eight Roads Ventures.
-
2020 IPO, Venture Capital and M&A Reports
6.29.2020WilmerHale’s annual IPO, Venture Capital and M&A Reports offer insights into market conditions and provide comprehensive statistics and analysis that are hard to find elsewhere.
-
2020 M&A Report
6.29.2020The 2020 M&A Report provides a detailed global M&A market review and outlook, as well as insights on key topics.
-
2020 IPO Report
6.29.2020The 2020 IPO Report offers a detailed IPO market review and outlook, plus useful market metrics and articles on topics of interest for pre-IPO companies.
-
2020 Venture Capital Report
6.29.2020The 2020 Venture Capital Report offers an in-depth US venture capital market review and outlook, including industry and regional breakdowns, as well as insights on a number of key topics.
-
COVID-19: Paycheck Protection Program Flexibility Act of 2020
6.8.2020On Friday, June 5, 2020, the Paycheck Protection Program Flexibility Act of 2020 (the Act) became law. The Act modifies previously adopted CARES Act provisions related to the Paycheck Protection Program administered by the U.S. Small Business Administration (SBA).
-
COVID-19: CARES Act—Updates to Main Street Lending Program
5.5.2020On April 30, 2020, the Federal Reserve announced actions to expand the Main Street Lending Program to three credit facilities (up from two) aimed at small and medium-sized businesses.
-
Privacy Law for Startups
5.1.2020In this article published by the American Bar Association Business Law Section, Kirk Nahra explains what startups need to know about privacy law.
